SHANDONG BOAN BIOTECH.H 1 (F:UJ9) — Stock Price
SHANDONG BOAN BIOTECH.H 1 (F:UJ9) is currently trading at €0.52 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.50 and €1.82. This page tracks SHANDONG BOAN BIOTECH.H 1's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see SHANDONG BOAN BIOTECH.H 1 market capitalisation.
SHANDONG BOAN BIOTECH.H 1 (UJ9) Stock Price Chart — Daily History & Trading Volume
The chart below tracks SHANDONG BOAN BIOTECH.H 1's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
SHANDONG BOAN BIOTECH.H 1 Income Statement — Revenue, Profit & Earnings by Year
SHANDONG BOAN BIOTECH.H 1's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €784.82 Million | €726.32 Million | €618.13 Million | €515.96 Million | €158.70 Million |
| Cost of Revenue | €222.39 Million | €183.66 Million | €209.16 Million | €161.73 Million | €52.19 Million |
| Gross Profit | €562.44 Million | €542.65 Million | €408.97 Million | €354.23 Million | €106.51 Million |
| Research & Development | €147.64 Million | €149.27 Million | €230.68 Million | €400.34 Million | €231.57 Million |
| SG&A | €382.08 Million | €332.30 Million | €308.22 Million | €296.42 Million | €96.21 Million |
| Total Operating Expenses | €744.25 Million | €621.82 Million | €722.29 Million | €842.19 Million | €375.71 Million |
| Operating Income | €40.57 Million | €104.50 Million | €-104.17 Million | €-326.23 Million | €-217.00 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €38.66 Million | €32.65 Million | €14.09 Million | €13.41 Million | €11.60 Million |
| Income Before Tax | €7.14 Million | €73.19 Million | €-119.38 Million | €-331.75 Million | €-225.42 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €7.14 Million | €73.19 Million | €-119.38 Million | €-331.75 Million | €-225.42 Million |
SHANDONG BOAN BIOTECH.H 1 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes SHANDONG BOAN BIOTECH.H 1's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €4.13 Billion | €2.85 Billion | €2.32 Billion | €2.20 Billion | €2.11 Billion |
| Total Current Assets | €2.01 Billion | €956.28 Million | €713.01 Million | €846.67 Million | €939.85 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | €81.86 Million |
| Net Receivables | €646.52 Million | €433.07 Million | €213.20 Million | €162.62 Million | €78.06 Million |
| Inventory | €129.96 Million | €168.25 Million | €165.29 Million | €143.52 Million | €98.84 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €1.39 Billion | €1.21 Billion | €1.00 Billion | €784.18 Million | €554.92 Million |
| Total Current Liabilities | €864.65 Million | €648.68 Million | €653.35 Million | €471.67 Million | €260.48 Million |
| Long-term Debt | €313.63 Million | €424.90 Million | €228.32 Million | €210.00 Million | €240.00 Million |
| Net Debt | — | €480.08 Million | €194.31 Million | €59.84 Million | — |
| Total Stockholder Equity | €2.74 Billion | €1.64 Billion | €1.32 Billion | €1.42 Billion | €1.55 Billion |
| Retained Earnings | €-554.02 Million | €-559.26 Million | €-631.11 Million | €-511.06 Million | €-176.10 Million |
SHANDONG BOAN BIOTECH.H 1 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how SHANDONG BOAN BIOTECH.H 1 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €64.89 Million | €-117.94 Million | €-18.57 Million | €-201.84 Million | €-246.28 Million |
| Capital Expenditures | €274.05 Million | €362.90 Million | €294.76 Million | €206.38 Million | €341.25 Million |
| Free Cash Flow | €-209.16 Million | €-480.84 Million | €-313.33 Million | €-408.22 Million | €-587.52 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €13.37 Million | €21.50 Million | €20.64 Million | €18.48 Million | €21.27 Million |
| Depreciation | €87.82 Million | €72.91 Million | €82.77 Million | €72.83 Million | €50.01 Million |
| Change in Cash | €931.75 Million | €-3.00 Million | €-29.05 Million | €-302.65 Million | €533.15 Million |
SHANDONG BOAN BIOTECH.H 1 Earnings History — EPS Actual vs. Analyst Estimates
Track SHANDONG BOAN BIOTECH.H 1's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 25, 2026 | — | — | — |
| Aug 27, 2025 | — | — | — |
| Mar 25, 2025 | — | — | — |